Coronavirus Eli Lilly Canada city Vancouver covid-19 bc coronavirus Coronavirus Eli Lilly Canada city Vancouver

B.C. to start clinical trials for previously rejected COVID-19 treatment

Reading now: 127
globalnews.ca

COVID-19 treatment that it had previously rejected and that has already been approved by Health Canada.The drug, known as bamlanivimab, is made by U.S.

pharmaceutical company Eli Lilly using technology from Vancouver-based biotech firm AbCellera. The company has donated $1 million to the province to support the clinical trials.The drug was given emergency federal approval in November and is meant for COVID-19 patients who are at risk of developing severe symptoms.The B.C.

government had declined to approve use of the drug, but will reconsider following the results of the local trials.[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]“We welcome more evidence to approve care and look forward to more data on this and.

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News